Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)

Intravenous immunoglobulin (IVIG), a pooled normal IgG from several thousand healthy donors and one of the commonly used immunotherapeutic molecules for the management of autoimmune and inflammatory diseases, has been explored for the treatment of coronavirus disease‐19 (COVID‐19). Although placebo‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Galeotti, Caroline, Kaveri, Srini V, Bayry, Jagadeesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
News & Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565103/
https://www.ncbi.nlm.nih.gov/pubmed/33088506
http://dx.doi.org/10.1002/cti2.1198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565103/
https://www.ncbi.nlm.nih.gov/pubmed/33088506
http://dx.doi.org/10.1002/cti2.1198

Ejemplares similares